Glaxosmithkline Pharma’s Q1 net dips 63% at Rs 26.42 crore

26 Jul 2017 Evaluate

Glaxosmithkline Pharmaceuticals has reported results for first quarter ended June 30, 2017.

The company has reported a fall of 63.44% in its net profit at Rs 26.42 crore for the quarter under review as compared to Rs 72.27 crore for the same quarter in the previous year. Total income of the company decreased by 14.89% at Rs 620.75 crore for Q1FY18 as compared Rs 729.35 crore for the corresponding quarter previous year.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.


Glaxosmithkline Phar Share Price

2065.40 -14.40 (-0.69%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.